Polg Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
POLG (DNA Polymerase Subunit Gamma, Catalytic) is the catalytic subunit of mitochondrial DNA polymerase, the only DNA polymerase responsible for replication and repair of mitochondrial DNA (mtDNA). It contains both polymerase and 3'-5' exonuclease activities. [@hudson2019]
Protein Information
Domain Structure
N-terminal exonuclease domain: 1-400 aa - 3'-5' proofreading activity
Linker region: 400-500 aa
Polymerase domain: 500-1100 aa - DNA synthesis
C-terminal region: 1100-1239 aa - subunit interaction
Molecular Function
POLG catalyzes mtDNA replication through its polymerase activity, while the exonuclease domain provides proofreading to maintain replication fidelity.
Enzyme Activities:
DNA polymerase activity: Adds nucleotides to growing DNA chain
3'-5' exonuclease activity: Proofreading and mismatch removal
5'-dRP lyase activity: Base excision repair
Role in Neurodegeneration
Parkinson's Disease
POLG mutations increase susceptibility to PD
Mitochondrial DNA deletions accumulate in PD substantia nigra
POLG mutations cause parkinsonism with PEO
mtDNA replication defects contribute to dopaminergic neuron loss
Alzheimer's Disease
POLG expression and activity reduced in AD brain
mtDNA depletion observed in AD [neurons](/entities/neurons)
Impaired mtDNA repair contributes to [amyloid-beta](/proteins/amyloid-beta) toxicity
Progressive External Ophthalmoplegia (PEO)
Autosomal dominant POLG mutations cause PEO with multiple mtDNA deletions
Accumulation of mtDNA deletions in muscle
Kearns-Sayre syndrome spectrum
Leigh Syndrome
POLG mutations can cause Leigh syndrome
Severe encephalopathy with bilateral lesions
Therapeutic Approaches
Interactions
TWNK: Mitochondrial DNA helicase
POLG2: Accessory subunit
SSBP1: Single-stranded binding protein
TFAM: Transcription factor for mtDNA
PRUNE2: Interacts with POLG function
Animal Models
Polg knockout mice are embryonic lethal
Mutator mice with proofreading deficiency accumulate mtDNA mutations
Zebrafish polg models show mitochondrial dysfunction
Gene therapy approaches to deliver functional POLG
Small molecule modulators of POLG activity
Understanding POLG dynamics in aging neurons
Developing mtDNA deletion detection assays
Screening for POLG mutations in early-onset Parkinson's disease
Background
The study of Polg Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data